000650 仁和药业
已收盘 08-05 15:00:00
资讯
新帖
简况
股市必读:仁和药业新发布《关于股份回购进展情况的公告》
证券之星 · 08-05 02:30
股市必读:仁和药业新发布《关于股份回购进展情况的公告》
股市必读:仁和药业新发布《关于股份回购进展情况的公告》
证券之星 · 08-04 02:06
股市必读:仁和药业新发布《关于股份回购进展情况的公告》
仁和药业(000650)7月31日股东户数8.82万户,较上期减少0.68%
证券之星 · 08-03 17:39
仁和药业(000650)7月31日股东户数8.82万户,较上期减少0.68%
仁和药业:公司有苯磺酸氨氯地平片、健心胶囊、大活络胶囊和安宫牛黄丸等
证券之星 · 08-03 16:00
仁和药业:公司有苯磺酸氨氯地平片、健心胶囊、大活络胶囊和安宫牛黄丸等
股市必读:仁和药业(000650)7月31日董秘有最新回复
证券之星 · 08-03
股市必读:仁和药业(000650)7月31日董秘有最新回复
股市必读:仁和药业(000650)7月29日董秘有最新回复
证券之星 · 07-30
股市必读:仁和药业(000650)7月29日董秘有最新回复
仁和药业:有ULOOK眼镜合作项目
证券之星 · 07-29
仁和药业:有ULOOK眼镜合作项目
股市必读:仁和药业(000650)7月24日董秘有最新回复
证券之星 · 07-27
股市必读:仁和药业(000650)7月24日董秘有最新回复
股市必读:仁和药业(000650)股东户数8.88万户,较上期减少0.34%
证券之星 · 07-24
股市必读:仁和药业(000650)股东户数8.88万户,较上期减少0.34%
仁和药业:截至2026年7月20日,大约8.88万户左右
证券之星 · 07-23
仁和药业:截至2026年7月20日,大约8.88万户左右
股市必读:仁和药业(000650)7月17日董秘有最新回复
证券之星 · 07-20
股市必读:仁和药业(000650)7月17日董秘有最新回复
仁和药业:2026年拟通过增加分红频次方式进一步增强投资者获得感
证券之星 · 07-17
仁和药业:2026年拟通过增加分红频次方式进一步增强投资者获得感
股市必读:仁和药业(000650)7月13日董秘有最新回复
证券之星 · 07-14
股市必读:仁和药业(000650)7月13日董秘有最新回复
仁和药业:截至2026年7月10日,大约8.91万户左右
证券之星 · 07-13
仁和药业:截至2026年7月10日,大约8.91万户左右
仁和药业:目前只有ULOOK眼镜合作项目
证券之星 · 07-09
仁和药业:目前只有ULOOK眼镜合作项目
股市必读:仁和药业(000650)7月7日董秘有最新回复
证券之星 · 07-08
股市必读:仁和药业(000650)7月7日董秘有最新回复
股市必读:仁和药业(000650)7月3日董秘有最新回复
证券之星 · 07-06
股市必读:仁和药业(000650)7月3日董秘有最新回复
股市必读:仁和药业(000650)7月1日董秘有最新回复
证券之星 · 07-02
股市必读:仁和药业(000650)7月1日董秘有最新回复
仁和药业:二冬汤颗粒在通过初步形式审查的目录外药品名单-基本目录(序号81)
证券之星 · 07-01
仁和药业:二冬汤颗粒在通过初步形式审查的目录外药品名单-基本目录(序号81)
仁和药业(000650)披露2025年年度股东会决议公告,6月26日股价下跌2.73%
证券之星 · 06-26
仁和药业(000650)披露2025年年度股东会决议公告,6月26日股价下跌2.73%
加载更多
公司概况
公司名称:
仁和药业股份有限公司
所属行业:
医药制造业
上市日期:
1996-12-10
主营业务:
仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是口服固体制剂、口服液体制剂、大容量注射剂、小容量注射剂、外用洗剂、搽剂、栓剂、软膏剂、健康相关产品。
发行价格:
6.26
{"stockData":{"symbol":"000650","market":"SZ","secType":"STK","nameCN":"仁和药业","latestPrice":5.39,"timestamp":1785913395000,"preClose":5.48,"halted":0,"volume":19747300,"delay":0,"changeRate":-0.0164,"floatShares":1331000000,"shares":1400000000,"eps":0.2638,"marketStatus":"已收盘","change":-0.09,"latestTime":"08-05 15:00:00","open":5.47,"high":5.48,"low":5.35,"amount":106000000,"amplitude":0.0237,"askPrice":5.39,"askSize":1489,"bidPrice":5.38,"bidSize":1144,"shortable":0,"etf":0,"ttmEps":0.2638,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785979800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.48,"symbolType":"stock","openAndCloseTimeList":[[1785893400000,1785900600000],[1785906000000,1785913200000]],"highLimit":6.03,"lowLimit":4.93,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1399938234,"isCdr":false,"pbRate":1.19,"roa":"--","peRate":20.432146,"roe":"2.2%","epsLYR":0.28,"committee":0.453851,"marketValue":7546000000,"turnoverRate":0.0148,"status":1,"floatMarketCap":7176000000},"requestUrl":"/m/hq/s/000650/","defaultTab":"news","newsList":[{"id":"2657256584","title":"股市必读:仁和药业新发布《关于股份回购进展情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657256584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657256584?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:30","pubTimestamp":1785868231,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘,仁和药业报收于5.48元,下跌0.18%,换手率0.95%,成交量12.61万手,成交额6940.14万元。公司公告汇总:截至2026年7月31日,仁和药业已累计回购股份17,000,050股,占总股本1.2143%,支付金额96,225,303.14元。公司公告汇总关于股份回购进展情况的公告仁和药业于2026年4月22日董事会审议通过以集中竞价方式回购股份方案,拟使用自有资金8,000万至15,000万元,回购价格不超过8.00元/股,用于股权激励或员工持股计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0188","BK0239","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656305745","title":"股市必读:仁和药业新发布《关于股份回购进展情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656305745","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656305745?lang=zh_cn&edition=full","pubTime":"2026-08-04 02:06","pubTimestamp":1785780375,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,仁和药业报收于5.49元,上涨1.1%,换手率1.32%,成交量17.62万手,成交额9638.59万元。股本股东变化:截至2026年7月31日,仁和药业股东户数为8.82万户,较7月20日减少600户,户均持股增至1.59万股。公司公告汇总:截至2026年7月31日,仁和药业已累计回购股份17,000,050股,占总股本1.2143%,支付金额96,225,303.14元。敬请发布截至7月末公司股东户数信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400001558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","000650","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656276203","title":"仁和药业(000650)7月31日股东户数8.82万户,较上期减少0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656276203","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656276203?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:39","pubTimestamp":1785749983,"startTime":"0","endTime":"0","summary":"证券之星消息,近日仁和药业披露,截至2026年7月31日公司股东户数为8.82万户,较7月20日减少600.0户,减幅为0.68%。在中药行业个股中,仁和药业股东户数高于行业平均水平,截至7月31日,中药行业平均股东户数为5.38万户。从股价来看,2026年7月20日至2026年7月31日,仁和药业区间跌幅为0.55%,在此期间股东户数减少600.0户,减幅为0.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300023853.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656218203","title":"仁和药业:公司有苯磺酸氨氯地平片、健心胶囊、大活络胶囊和安宫牛黄丸等","url":"https://stock-news.laohu8.com/highlight/detail?id=2656218203","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656218203?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:00","pubTimestamp":1785744046,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)08月03日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘您好!请问对于即将到来的老龄化时代公司是否有针对老年人慢性病的药物?如高血压,心脑血管,糖尿病之类的,作为江西樟 帮制药中药龙头企业,公司未来有什么大的发展或并购方案吗?仁和药业回复:尊敬的投资者,您好!关于您提到的产品,公司有苯磺酸氨氯地平片、健心胶囊、大活络胶囊和安宫牛黄丸等,具体内容建议您查看公司官网。关于公司未来发展情况,建议您查阅公司2025年度报告全文版之公司未来发展的展望章节。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300017914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656482913","title":"股市必读:仁和药业(000650)7月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2656482913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656482913?lang=zh_cn&edition=full","pubTime":"2026-08-03 01:42","pubTimestamp":1785692531,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,仁和药业报收于5.43元,下跌1.09%,换手率1.78%,成交量23.73万手,成交额1.29亿元。董秘最新回复投资者: 董秘您好!贵公司年报中披露投资的股票和基金是否在高位套现?届时会在公司2026年半年报证券投资情况里面披露,请留意公司公告。当日关注点交易信息汇总:7月31日主力资金净流入780.91万元,占总成交额6.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300000663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0188","BK0239","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655338818","title":"股市必读:仁和药业(000650)7月29日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655338818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655338818?lang=zh_cn&edition=full","pubTime":"2026-07-30 02:12","pubTimestamp":1785348733,"startTime":"0","endTime":"0","summary":"截至2026年7月29日收盘,仁和药业报收于5.47元,上涨1.48%,换手率1.25%,成交量16.67万手,成交额9089.84万元。董秘最新回复投资者: 你好!2026年7月上交会上深圳必爱智能创始人李晓涛博士作为特邀嘉宾,发布了U look第二代智能脑机接口眼镜。这个问题在今年7月8日互动易平台回复过,有ULOOK眼镜合作项目。当日关注点交易信息汇总:7月29日主力资金净流出111.47万元,游资资金净流出972.5万元,散户资金净流入1083.97万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000001178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655858615","title":"仁和药业:有ULOOK眼镜合作项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2655858615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655858615?lang=zh_cn&edition=full","pubTime":"2026-07-29 11:33","pubTimestamp":1785295988,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)07月29日在投资者关系平台上答复投资者关心的问题。投资者提问:你好!2026年7月上交会上深圳必爱智能创始人李晓涛博士作为特邀嘉宾,发布了U look第二代智能脑机接口眼镜。请问,作为合作伙伴,目前为止,贵司还与必爱智能科技合作开发智能脑机接口眼镜吗?谢谢!仁和药业回复:尊敬的投资者您好!这个问题在今年7月8日互动易平台回复过,有ULOOK眼镜合作项目。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900015527.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0188","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654306417","title":"股市必读:仁和药业(000650)7月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2654306417","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654306417?lang=zh_cn&edition=full","pubTime":"2026-07-27 02:21","pubTimestamp":1785090071,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘,仁和药业报收于5.26元,下跌2.05%,换手率1.17%,成交量15.57万手,成交额8302.1万元。董秘最新回复投资者: 董秘您好!请您详细查阅公司2026年第8号公告《关于授权董事会制定2026年中期分红方案的公告》,里面详细披露了关于中期分红的相关情况。交易信息汇总资金流向7月24日主力资金净流出146.16万元,占总成交额0.0%;游资资金净流出509.8万元,占总成交额0.0%;散户资金净流入655.97万元,占总成交额0.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700001118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000650","BK0097","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653720879","title":"股市必读:仁和药业(000650)股东户数8.88万户,较上期减少0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653720879","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653720879?lang=zh_cn&edition=full","pubTime":"2026-07-24 02:15","pubTimestamp":1784830514,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘,仁和药业报收于5.37元,上涨0.94%,换手率1.17%,成交量15.63万手,成交额8362.37万元。股本股东变化:截至7月20日股东户数为8.88万户,较7月10日减少300户,减幅0.34%;户均持股由1.57万股增至1.58万股。交易信息汇总资金流向7月23日主力资金净流出148.06万元,占总成交额0.0%;游资资金净流出749.36万元,占总成交额0.0%;散户资金净流入897.41万元,占总成交额0.0%。董秘: 谢谢您的关注,截至2026年7月20日,大约8.88万户左右。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400001539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","000650","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653713902","title":"仁和药业:截至2026年7月20日,大约8.88万户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2653713902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653713902?lang=zh_cn&edition=full","pubTime":"2026-07-23 11:44","pubTimestamp":1784778276,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)07月23日在投资者关系平台上答复投资者关心的问题。投资者提问:你好!请问,截止26年7月21日贵公司股东人数为多少?谢谢!仁和药业回复:谢谢您的关注,截至2026年7月20日,大约8.88万户左右。具体数据,根据相关法规,请您先向公司证券部提交股东身份证明,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300020060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","000650","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652325219","title":"股市必读:仁和药业(000650)7月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2652325219","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652325219?lang=zh_cn&edition=full","pubTime":"2026-07-20 01:06","pubTimestamp":1784480772,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,仁和药业报收于5.41元,下跌1.81%,换手率2.68%,成交量35.7万手,成交额1.96亿元。董秘最新回复投资者: 你好!杭州飞镖夏焱创业投资合伙企业:该基金于2023年2月通过贵公司董事会决议参与,总投资额8000万元,仁和药业占比20%。贵公司2025年年报显示,2026年中期有分配预案。公司高度重视对投资者的合理回报,2023年至2025年三年现金分红近7亿元。贵公司2025年年报显示,2025年公司计提了约1.1亿左右的商誉减值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000000547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652058124","title":"仁和药业:2026年拟通过增加分红频次方式进一步增强投资者获得感","url":"https://stock-news.laohu8.com/highlight/detail?id=2652058124","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652058124?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:18","pubTimestamp":1784276287,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)07月17日在投资者关系平台上答复投资者关心的问题。投资者提问:你好!贵公司2025年年报显示,2026年中期有分配预案。请问,贵公司为了提增股东与员工的信心,会努力实施此预案吗?谢谢!仁和药业回复:尊敬的投资者,您好!公司高度重视对投资者的合理回报,2023年至2025年三年现金分红近7亿元。2026年在确保公司持续稳健经营及长远发展的前提下,公司拟通过增加分红频次方式进一步增强投资者获得感。后续分红安排请您关注公司公告。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700029618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651314681","title":"股市必读:仁和药业(000650)7月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651314681","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651314681?lang=zh_cn&edition=full","pubTime":"2026-07-14 01:44","pubTimestamp":1783964653,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘,仁和药业报收于5.37元,上涨2.09%,换手率2.2%,成交量29.34万手,成交额1.58亿元。董秘最新回复投资者: 你好!公司暂无应披露而未披露的信息,请关注公司后续公告。敬请发布7月上旬末公司股东户数信息。董秘: 谢谢您的关注,截至2026年7月10日,大约8.91万户左右。当日关注点交易信息汇总:7月13日主力资金净流出514.74万元,游资资金净流出593.22万元,散户资金净流入1107.96万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400001323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651192735","title":"仁和药业:截至2026年7月10日,大约8.91万户左右","url":"https://stock-news.laohu8.com/highlight/detail?id=2651192735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651192735?lang=zh_cn&edition=full","pubTime":"2026-07-13 16:57","pubTimestamp":1783933026,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)07月13日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘,您好!敬请发布7月上旬末公司股东户数信息。谢谢!致礼!仁和药业回复:谢谢您的关注,截至2026年7月10日,大约8.91万户左右。具体数据,根据相关法规,请您先向公司证券部提交股东身份证明,谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300023992.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0097","000650"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650294808","title":"仁和药业:目前只有ULOOK眼镜合作项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2650294808","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650294808?lang=zh_cn&edition=full","pubTime":"2026-07-09 11:34","pubTimestamp":1783568064,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业(000650)07月08日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好!贵公司与深圳必爱智能科技合作研发的产品有哪些?合作研发的产品各个研发进展如何?有哪些已经上市销售?仁和药业回复:尊敬的投资者您好:目前只有ULOOK眼镜合作项目。谢谢!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900016889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0188","BK0239","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649340689","title":"股市必读:仁和药业(000650)7月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649340689","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649340689?lang=zh_cn&edition=full","pubTime":"2026-07-08 02:33","pubTimestamp":1783449191,"startTime":"0","endTime":"0","summary":"截至2026年7月7日收盘,仁和药业报收于5.24元,下跌3.14%,换手率1.27%,成交量16.94万手,成交额8945.16万元。董秘最新回复投资者: 你好!请问,截止26年6月30号,公司股东人数是多少?2026年6月30日公司股东人数会在公司2026半年报里面披露,请您留意公司半年度报告。当日关注点交易信息汇总:7月7日主力资金净流出520.63万元,散户资金净流入550.9万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800001339.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649616372","title":"股市必读:仁和药业(000650)7月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649616372","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649616372?lang=zh_cn&edition=full","pubTime":"2026-07-06 01:41","pubTimestamp":1783273270,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘,仁和药业报收于5.37元,上涨2.48%,换手率2.12%,成交量28.28万手,成交额1.51亿元。董秘最新回复投资者: 你好!公司公告汇总:截至2026年6月30日,仁和药业已累计回购16,740,050股,占总股本1.1958%,支付总金额94,847,116.56元,回购进展符合方案要求。交易信息汇总资金流向7月3日主力资金净流出2460.36万元,占总成交额0.0%;游资资金净流入869.63万元,占总成交额0.0%;散户资金净流入1590.73万元,占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600000575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0097","000650","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648525195","title":"股市必读:仁和药业(000650)7月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648525195","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648525195?lang=zh_cn&edition=full","pubTime":"2026-07-02 04:02","pubTimestamp":1782936138,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘,仁和药业报收于5.18元,上涨1.77%,换手率1.26%,成交量16.76万手,成交额8586.92万元。目前,证券部无应披露而未披露的信息。最新消息,国家医保局6月29日对通过2026年目录初审的药品名单和主要信息进行了公示,其中557个。交易信息汇总资金流向7月1日主力资金净流出425.4万元,占总成交额0.0%;游资资金净流出133.66万元,占总成交额0.0%;散户资金净流入559.05万元,占总成交额0.0%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200001899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","000650","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648518382","title":"仁和药业:二冬汤颗粒在通过初步形式审查的目录外药品名单-基本目录(序号81)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648518382","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648518382?lang=zh_cn&edition=full","pubTime":"2026-07-01 15:04","pubTimestamp":1782889459,"startTime":"0","endTime":"0","summary":"证券之星消息,仁和药业07月01日在投资者关系平台上答复投资者关心的问题。最新消息,国家医保局6月29日对通过2026年目录初审的药品名单和主要信息进行了公示,其中557个。54个药品分别通过了基本医保药品目录、商保创新药目录初步形式审查,请问仁和药业有多少个药品通过了初步审查?另外,公司清肺汤颗粒在目录外预申报药品名单。本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100023567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","000650","BK0239","BK0097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646365578","title":"仁和药业(000650)披露2025年年度股东会决议公告,6月26日股价下跌2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646365578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646365578?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:31","pubTimestamp":1782484273,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,仁和药业报收于4.99元,较前一交易日下跌2.73%,最新总市值为69.86亿元。该股当日开盘5.11元,最高5.15元,最低4.98元,成交额达8517.25万元,换手率为1.27%。近日,仁和药业发布《公司2025年年度股东会决议公告》。江西求正沃德律师事务所对本次会议出具法律意见书,认为会议表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600045763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000650","BK0097","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1785966361511,"stockEarnings":[{"period":"1week","weight":-0.0146},{"period":"1month","weight":0.0234},{"period":"3month","weight":-0.0269},{"period":"6month","weight":-0.0694},{"period":"1year","weight":-0.0647},{"period":"ytd","weight":-0.02}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":-0.0403},{"period":"3month","weight":-0.0722},{"period":"6month","weight":-0.046},{"period":"1year","weight":0.0721},{"period":"ytd","weight":-0.0228}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"仁和药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"88200人(较上一季度减少0.68%)","perCapita":"15095股","listingDate":"1996-12-10","address":"江西省宜春市樟树市葛玄路6号","registeredCapital":"139993万元","survey":" 仁和药业股份有限公司的主营业务是药品及大健康产品的生产和销售。公司的主要产品是口服固体制剂、口服液体制剂、大容量注射剂、小容量注射剂、外用洗剂、搽剂、栓剂、软膏剂、健康相关产品。","listedPrice":6.26},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"仁和药业,000650,仁和药业股票,仁和药业股票老虎,仁和药业股票老虎国际,仁和药业行情,仁和药业股票行情,仁和药业股价,仁和药业股市,仁和药业股票价格,仁和药业股票交易,仁和药业股票购买,仁和药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"仁和药业(000650)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供仁和药业(000650)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}